Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 3, 2009, Pages 323-329

  Paulsen, L ^a,b   Holst, L M ^a   Bech, J N ^a   Starklint, J ^a   Pedersen, E B ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b HOLSTEBRO HOSPITAL   (Denmark)

Author keywords

Aldosterone; Aquaporin; Atorvastatin; Blood pressure; Glomerular filtration rate; Renin; Sodium

Indexed keywords

ALDOSTERONE; AQUAPORIN 2; ATORVASTATIN; HORMONE; PLACEBO; RENIN; SODIUM; SODIUM CHLORIDE; WATER; ANGIOTENSIN II; AQP2 PROTEIN, HUMAN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HEPTANOIC ACID DERIVATIVE; LITHIUM; PYRROLE DERIVATIVE; VASOPRESSIN DERIVATIVE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CALORIE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; EVENING DOSAGE; FEMALE; FLUID INTAKE; FREE WATER CLEARANCE; GLOMERULUS FILTRATION RATE; HIGH SODIUM INTAKE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; KIDNEY TUBULE FUNCTION; MALE; MORNING DOSAGE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; SODIUM URINE LEVEL; URINARY EXCRETION; BLOOD; DRUG EFFECT; KIDNEY FUNCTION TEST; URINE;

ADULT; ALDOSTERONE; ANGIOTENSIN II; AQUAPORIN 2; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; HEPTANOIC ACIDS; HUMANS; KIDNEY FUNCTION TESTS; LITHIUM; MALE; NATRIURETIC PEPTIDE, BRAIN; PYRROLES; RENIN; SODIUM; VASOPRESSINS;

EID: 67649827350     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510802571007     Document Type: Article

References (27)

1. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999;20:725-41.
2. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58.
3. Kido M, Ando K, Oba S, Fujita T. Renoprotective effect of pravastatin in salt-loaded Dahl salt-sensitive rats. Hypertens Res 2005;28:1009-15.
4. Wilson SH, Chade AR, Feldstein A, Sawamura T, Napoli C, Lerman A, Lerman LO. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholestero-laemia. Nephrol Dial Transpl 2003;18:703-9.
5. Bayorh MA, Layas MF, Mann G, Feuerstein GZ, Eatman D. The effect of diet on simvastatin and losartan enhancement of endothelial function. Clin Exp Hypertens 2007;29:311-25.
6. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006;17:2006-16.
7. Tonelli M, Moye L, Sacks FM, Cole T, Curhan GC. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003;14:1605-13.
8. van Dijk MA, Kamper AM, van VS, Souverijn JH, Blauw GJ. Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease. Nephrol Dial Transpl 2001;16: 2152-7.
9. Paulsen L, Holm C, Bech JN, Starklint J, Pedersen EB. Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. Nephrol Dial Transpl 2008;23:1556-61.
10. Pedersen EB, Eiskjaer H, Madsen B, Danielsen H, Egeblad M, Nielsen CB. Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transpl 1993;8:1064-70.
11. Jensen KT, Carstens J, Ivarsen P, Pedersen EB. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997;57:529-40.
12. Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 2001;280:F860-7.
13. Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension 1997;30:968-74.
14. Inman SR, Caprio TW, Drummond E, Mueller M, Entenman K. Enhanced acetylcholine-induced dilation in afferent arterioles in simvastatin-fed rats. Vascul Pharmacol 2006;44:17-21.
15. Nesic Z, Todorovic Z, Stojanovic R, Basta-Jovanovic G, Radojevic-Skodric S, Velickovic R, Chatterjee PK, Thiemermann C, Prostran M. Single-dose intravenous simvasta-tin treatment attenuates renal injury in an experimental model of ischemia-reperfusion in the rat. J Pharmacol Sci 2006;102:413-17.
16. Athyros VG, Mikhailidis DP, Liberopoulos EN, Kakafika AI, Karagiannis A, Papageorgiou AA, Tziomalos K, Ganotakis ES, Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transpl 2007;22:118-27.
17. Atthobari J, Brantsma AH, Gansevoort RT, Visser ST, Asselbergs FW, van Gilst WH, de Jong PE, de Jong-van den Berg LT. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Nephrol Dial Transpl 2006;21:3106-14.
18. Strippoli GF, Navaneethan SD, Johnson DW, Perkovic V, Pellegrini F, Nicolucci A, Craig JC. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. Br Med J 2008;336:645-51.
19. Ishikawa S, Kawasumi M, Saito T. Simvastatin inhibits the cellular signaling and proliferative action of arginine vaso-pressin in cultured rat glomerular mesangial cells. Endocrinology 1995;136:1954-61.
20. Ide H, Fujiya S, Aanuma Y, Agishi Y. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones. Clin Ther 1990;12:410-20.
21. Strey CH, Young JM, Lainchbury JH, Frampton CM, Nicholls MG, Richards AM, Scott RS. Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure. Heart 2006;92:1603-9.
22. Emberson JR, Ng LL, Armitage J, Bowman L, Parish S, Collins R. N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/ BHF heart protection study. J Am Coll Cardiol 2007;49:311-19.
23. van der Linde NA, Sijbrands EJ, Boomsma F, van den Meiracker AH. Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin. Hypertension 2006;47:1125-30.
24. de SS, Nielsen J, Olesen ET, Dimke H, Kwon TH, Frokiaer J, Nielsen S. Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney. Am J Physiol Renal Physiol 2007;293:F87-99.
25. Milionis HJ, Liberopoulos EN, Achimastos A, Elisaf MS, Mikhailidis DP. Statins: another class of antihypertensive agents? J Hum Hypertens 2006;20:320-35.
26. He FJ, MacGregor GA. How far should salt intake be reduced? Hypertension 2003;42:1093-9.
27. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER III, Simons-Morton DG, Karanja N, Lin PH. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.